Diet and glycaemia: The markers and their meaning. A report of the Unilever Nutrition Workshop

British Journal of Nutrition

Volumn 113, Issue 2, 2015, Pages 239-248

  Alssema, Marjan ^a,b   Boers, Hanny M ^a   Ceriello, Antonio ^c   Kilpatrick, Eric S ^d   Mela, David J ^a   Priebe, Marion G ^e   Schrauwen, Patrick ^f   Wolffenbuttel, Bruce H ^e   Pfeiffer, Andreas F H ^g,h  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g Department of Endocrinology University of Groningen University Medical Center Groningen Groningen ^*  (Germany)

^h GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Diet; Fructosamine; Glycaemia; Glycated Hb

Indexed keywords

1,5 ANHYDROSORBITOL; ADVANCED GLYCATION END PRODUCT; FRUCTOSAMINE; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; BIOLOGICAL MARKER; CARBOHYDRATE DIET;

ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; DIABETIC PATIENT; DIET; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; METABOLIC DISORDER; WORKSHOP; ADVERSE EFFECTS; BLOOD; CARBOHYDRATE DIET; FOOD HANDLING; GLYCEMIC LOAD; HYPERGLYCEMIA; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; ORGANIZATION;

BIOMARKERS; BIOMEDICAL RESEARCH; CONGRESSES AS TOPIC; DIET; DIETARY CARBOHYDRATES; FOOD HANDLING; GLYCEMIC LOAD; HUMANS; HYPERGLYCEMIA; RESEARCH DESIGN;

EID: 84927555579     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514003547     Document Type: Article

References (84)

1. Blaak EE, Antoine JM, Benton D, et al. (2012) Impact of postprandial glycaemia on health and prevention of disease. Obes Rev 13, 923-984.
2. International Diabetes Federation (2011) Guideline for management of postmeal glucose in diabetes. www.idf.org/2011-guideline-management-postmeal-glucose-diabetes (accessed May 2014).
3. EFSA Panel on Dietetic Products NaAN (2012) Guidance on the scientific requirements for health claims related to appetite ratings, weight management, and blood glucose concentrations. EFSA J 10, 2604.
4. Unilever (2014) Unilever sustainable living plan: small actions, big difference. www.unilever.com/sustainableliving-2014 (accessed May 2014).
5. Van de Laar FA, Lucassen PL, Akkermans RP, et al. (2006) Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose. The Cochrane Database of Systematic Reviews 2006, issue 4, CD005061.
6. Van de Laar FA, Lucassen PL, Akkermans RP, et al. (2005) Alpha-glucosidase inhibitors for type 2 diabetes mellitus. The Cochrane Database of Systematic Reviews 2005, issue 2, CD003639.
7. Thomas D & Elliott EJ (2009) Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. The Cochrane Database of Systematic Reviews 2009, issue 1, CD006296.
8. Livesey G, Taylor R, Hulshof T, et al. (2008) Glycemic response and health-a systematic review and metaanalysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 87, 258S-268S.
9. Dong JY, Zhang L, Zhang YH, et al. (2011) Dietary glycaemic index and glycaemic load in relation to the risk of type 2 diabetes: a meta-analysis of prospective cohort studies. Br J Nutr 106, 1649-1654.
10. Fan J, Song Y, Wang Y, et al. (2012) Dietary glycemic index, glycemic load, and risk of coronary heart disease, stroke, and stroke mortality: a systematic review with meta-analysis. PLOS ONE 7, e52182.
11. Zhang Y, Hu G, Yuan Z, et al. (2012) Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLOS ONE 7, e42551.
12. Goyenechea E, Holst C, Saris WH, et al. (2011) Effects of different protein content and glycemic index of ad libitum diets on diabetes risk factors in overweight adults: the DIOGenes multicentre, randomised, dietary intervention trial. Diabetes Metab Res Rev 27, 705-716.
13. Kelly S, Frost G, Whittaker V, et al. (2004) Low glycaemic index diets for coronary heart disease. The Cochrane Database of Systematic Reviews 2004, issue 4, CD004467.
14. Preiss D, Thomas LE, Sun JL, et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open 2, e001925.
15. Hanefeld M, Fischer S, Schmechel H, et al. (1991) Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM. Diabetes Care 14, 308-317.
16. Rudovich N, Pivovarova O, Traberth A, et al. (2012) Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway? Diabetologia 55, 3392-3395.
17. Browning JD, Baker JA, Rogers T, et al. (2011) Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr 93, 1048-1052.
18. Wolever TM, Gibbs AL, Mehling C, et al. (2008) The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 87, 114-125.
19. Gogebakan O, Kohl A, Osterhoff MA, et al. (2011) Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation 124, 2829-2838.
20. Tuomilehto J, Lindstrom J, Eriksson JG, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344, 1343-1350.
21. Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393-403.
22. Estruch R, Ros E, Salas-Salvado J, et al. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368, 1279-1290.
23. McMillan-Price J, Petocz P, Atkinson F, et al. (2006) Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med 166, 1466-1475.
24. Akhavan T, Luhovyy BL, Brown PH, et al. (2010) Effect of premeal consumption of whey protein and its hydrolysate on food intake and postmeal glycemia and insulin responses in young adults. Am J Clin Nutr 91, 966-975.
25. Sluijs I, Beulens JW, van der AD, et al. (2010) Dietary intake of total, animal, and vegetable protein and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-NL study. Diabetes Care 33, 43-48.
26. de Munter JS, Hu FB, Spiegelman D, et al. (2007) Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med 4, e261.
27. McKeown NM, Meigs JB, Liu S, et al. (2002) Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76, 390-398.
28. McKeown NM, Meigs JB, Liu S, et al. (2004) Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort. Diabetes Care 27, 538-546.
29. Weickert MO, Roden M, Isken F, et al. (2011) Effects of supplemented isoenergetic diets differing in cereal fiber and protein content on insulin sensitivity in overweight humans. Am J Clin Nutr 94, 459-471.
30. Steele R, Wall JS, De Bodo RC, et al. (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187, 15-24.
31. De Bodo RC, Steele R, Altszuler N, et al. (1963) On the hormonal regulation of carbohydrate metabolism: studies with C14 glucose. Recent Prog Horm Res 19, 445-488.
32. Tissot S, Normand S, Guilluy R, et al. (1990) Use of the new gas chromatograph isotope ratio mass spectrometer to trace exogenous 13C labelled glucose at a very low level of enrichment in man. Diabetologia 33, 449-456.
33. Eelderink C, Schepers M, Preston T, et al. (2012) Slowly and rapidly digestible starchy foods can elicit a similar glycemic response because of differential tissue glucose uptake in healthy men. Am J Clin Nutr 96, 1017-1024.
34. Schenk S, Davidson CJ, Zderic TW, et al. (2003) Different glycemic indexes of breakfast cereals are not due to glucose entry into blood but to glucose removal by tissue. Am J Clin Nutr 78, 742-748.
35. Priebe MG, Wachters-Hagedoorn RE, Heimweg JA, et al. (2008) An explorative study of in vivo digestive starch characteristics and postprandial glucose kinetics of wholemeal wheat bread. Eur J Nutr 47, 417-423.
36. Englyst KN, Englyst HN, Hudson GJ, et al. (1999) Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am J Clin Nutr 69, 448-454.
37. Eelderink C, Moerdijk-Poortvliet TC, Wang H, et al. (2012) The glycemic response does not reflect the in vivo starch digestibility of fiber-rich wheat products in healthy men. J Nutr 142, 258-263.
38. Brownlee M & Hirsch IB (2006) Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295, 1707-1708.
39. Ceriello A & Ihnat MA (2010) 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 27, 862-867.
40. Salardi S, Zucchini S, Santoni R, et al. (2002) The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care 25, 1840-1844.
41. Ceriello A, Esposito K, Piconi L, et al. (2008) Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 57, 1349-1354.
42. Monnier L, Mas E, Ginet C, et al. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681-1687.
43. Standl E, Schnell O & Ceriello A (2011) Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 34, Suppl. 2, S120-S127.
44. Hill NR, Oliver NS, Choudhary P, et al. (2011) Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 13, 921-928.
45. Kuenen JC, Borg R, Kuik DJ, et al. (2011) Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? Diabetes Care 34, 1843-1847.
46. Wojcicki JM (1995) "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 27, 41-42.
47. Service FJ, Molnar GD, Rosevear JW, et al. (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19, 644-655.
48. McDonnell CM, Donath SM, Vidmar SI, et al. (2005) A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 7, 253-263.
49. Kovatchev BP, Cox DJ, Kumar A, et al. (2003) Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 5, 817-828.
50. Kovatchev BP, Clarke WL, Breton M, et al. (2005) Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application. Diabetes Technol Ther 7, 849-862.
51. Kovatchev BP, Otto E, Cox D, et al. (2006) Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 29, 2433-2438.
52. Suwa T, Ohta A, Matsui T, et al. (2010) Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocrinol J 57, 135-140.
53. Selvin E, Steffes MW, Zhu H, et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362, 800-811.
54. Goldstein DE, Little RR, Wiedmeyer HM, et al. (1986) Glycated hemoglobin: methodologies and clinical applications. Clin Chem 32, B64-B70.
55. Nathan DM, Kuenen J, Borg R, et al. (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31, 1473-1478.
56. Monnier L, Lapinski H & Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26, 881-885.
57. Montagnana M, Paleari R, Danese E, et al. (2013) Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects. Clin Chim Acta 423, 1-4.
58. Sakuma N, Omura M, Oda E, et al. (2011) Converse contributions of fasting and postprandial glucose to HbA1c and glycated albumin. Diabetol Int 2, 162-171.
59. Selvin E, Francis LM, Ballantyne CM, et al. (2011) Nontraditional markers of glycemia: associations with microvascular conditions. Diabetes Care 34, 960-967.
60. Nathan DM, McGee P, Steffes MW, et al. (2014) Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes 63, 282-290.
61. Dungan KM, Buse JB, Largay J, et al. (2006) 1,5-Anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care 29, 1214-1219.
62. Juraschek SP, Steffes MW & Selvin E (2012) Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem 58, 1648-1655.
63. Chiasson JL, Josse RG, Gomis R, et al. (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290, 486-494.
64. Raz I, Wilson PW, Strojek K, et al. (2009) Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 32, 381-386.
65. Holman RR, Haffner SM, McMurray JJ, et al. (2010) Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med 362, 1463-1476.
66. DECODE study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354, 617-621.
67. Cavalot F, Petrelli A, Traversa M, et al. (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocrinol Metab 91, 813-819.
68. Juraschek SP, Steffes MW, Miller ER, et al. (2012) Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care 35, 2265-2270.
69. Sakaguchi K, Hirota Y, Hashimoto N, et al. (2012) A minimally invasive system for glucose area under the curve measurement using interstitial fluid extraction technology: evaluation of the accuracy and usefulness with oral glucose tolerance tests in subjects with and without diabetes. Diabetes Technol Ther 14, 485-491.
70. Wolffenbuttel BH, Giordano D, Founds HW, et al. (1996) Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 347, 513-515.
71. Meerwaldt R, Graaff R, Oomen PH, et al. (2004) Simple noninvasive assessment of advanced glycation endproduct accumulation. Diabetologia 47, 1324-1330.
72. Meerwaldt R, Lutgers HL, Links TP, et al. (2007) Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30, 107-112.
73. Lutgers HL, Gerrits EG, Graaff R, et al. (2009) Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 52, 789-797.
74. Willemsen S, Hartog JW, Hummel YM, et al. (2011) Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients. Eur J Heart Fail 13, 76-82.
75. de Vos LC, Mulder DJ, Smit AJ, et al. (2014) Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol 34, 933-938.
76. Jansen H, Stolk RP, Nolte IM, et al. (2013) Determinants of HbA1c in nondiabetic Dutch adults: genetic loci and clinical and lifestyle parameters, and their interactions in the Lifelines Cohort Study. J Intern Med 273, 283-293.
77. Snieder H, Sawtell PA, Ross L, et al. (2001) HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes 50, 2858-2863.
78. Soranzo N, Sanna S, Wheeler E, et al. (2010) Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239.
79. Wolffenbuttel BH, Herman WH, Gross JL, et al. (2013) Ethnic differences in glycemic markers in patients with type 2 diabetes. Diabetes Care 36, 2931-2936.
80. Poulsen MW, Hedegaard RV, Andersen JM, et al. (2013) Advanced glycation endproducts in food and their effects on health. Food Chem Toxicol 60, 10-37.
81. Tsujino D, Nishimura R, Taki K, et al. (2009) Daily glucose profiles in Japanese people with normal glucose tolerance as assessed by continuous glucose monitoring. Diabetes Technol Ther 11, 457-460.
82. Mazze RS, Strock E, Wesley D, et al. (2008) Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 10, 149-159.
83. Borg R, Kuenen JC, Carstensen B, et al. (2010) Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia 53, 1608-1611.
84. Nomura K, Saitoh T, Kim GU, et al. (2011) Glycemic profiles of healthy individuals with low fasting plasma glucose and HbA1c. ISRN Endocrinol 2011, 435047.